Steven P. Gelone Nabriva Therapeutics PLC (NBRV) insider trading activity

Steven P. Gelone is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 14,283 shares of NBRV, which is worth approximately $5,713. The most recent transaction as insider was on Jan 29, 2022, when has been sold 3,483 shares (Ordinary Shares) at a price of $0.45 per share, resulting in proceeds of $1,567. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K

0% 3M change

0% 12M change

Total Value Held $5,713

Steven P. Gelone Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2022	SELL Payment of exercise price or tax liability	$1,567 $0.45 p/Share	3,483 Reduced 0.95%	362,540 Ordinary Shares
Jan 06 2022	SELL Payment of exercise price or tax liability	$64 $0.58 p/Share	110 Reduced 0.03%	366,023 Ordinary Shares
Dec 31 2021	SELL Payment of exercise price or tax liability	$38 $0.6 p/Share	63 Reduced 0.02%	366,133 Ordinary Shares
Dec 06 2021	SELL Payment of exercise price or tax liability	$66 $0.72 p/Share	92 Reduced 0.03%	366,196 Ordinary Shares
Nov 30 2021	SELL Payment of exercise price or tax liability	$49 $0.78 p/Share	63 Reduced 0.02%	366,288 Ordinary Shares
Nov 06 2021	SELL Payment of exercise price or tax liability	$122 $1.33 p/Share	92 Reduced 0.03%	366,351 Ordinary Shares
Oct 31 2021	SELL Payment of exercise price or tax liability	$72 $1.15 p/Share	63 Reduced 0.02%	366,443 Ordinary Shares
Oct 06 2021	SELL Payment of exercise price or tax liability	$99 $1.08 p/Share	92 Reduced 0.03%	366,506 Ordinary Shares
Sep 30 2021	SELL Payment of exercise price or tax liability	$75 $1.19 p/Share	63 Reduced 0.02%	366,598 Ordinary Shares
Sep 06 2021	SELL Payment of exercise price or tax liability	$103 $1.11 p/Share	93 Reduced 0.03%	366,661 Ordinary Shares
Aug 31 2021	SELL Payment of exercise price or tax liability	$67 $1.06 p/Share	63 Reduced 0.02%	366,754 Ordinary Shares
Aug 06 2021	SELL Payment of exercise price or tax liability	$108 $1.17 p/Share	92 Reduced 0.03%	366,817 Ordinary Shares
Jul 31 2021	SELL Payment of exercise price or tax liability	$69 $1.1 p/Share	63 Reduced 0.02%	366,909 Ordinary Shares
Jul 06 2021	SELL Payment of exercise price or tax liability	$117 $1.27 p/Share	92 Reduced 0.03%	366,972 Ordinary Shares
Jun 30 2021	SELL Payment of exercise price or tax liability	$85 $1.35 p/Share	63 Reduced 0.02%	367,064 Ordinary Shares
Jun 06 2021	SELL Payment of exercise price or tax liability	$123 $1.34 p/Share	92 Reduced 0.03%	367,127 Ordinary Shares
May 31 2021	SELL Payment of exercise price or tax liability	$87 $1.38 p/Share	63 Reduced 0.02%	367,219 Ordinary Shares
May 06 2021	SELL Payment of exercise price or tax liability	$137 $1.49 p/Share	92 Reduced 0.03%	367,282 Ordinary Shares
Apr 30 2021	SELL Payment of exercise price or tax liability	$112 $1.78 p/Share	63 Reduced 0.02%	367,374 Ordinary Shares
Apr 28 2021	BUY Grant, award, or other acquisition	-	290,697 Added 44.17%	367,437 Ordinary Shares
Apr 06 2021	SELL Payment of exercise price or tax liability	$159 $1.73 p/Share	92 Reduced 0.12%	76,740 Ordinary Shares
Mar 31 2021	SELL Payment of exercise price or tax liability	$105 $1.66 p/Share	63 Reduced 0.08%	78,028 Ordinary Shares
Mar 06 2021	SELL Payment of exercise price or tax liability	$165 $1.79 p/Share	92 Reduced 0.12%	76,832 Ordinary Shares
Feb 28 2021	SELL Payment of exercise price or tax liability	$151 $2.39 p/Share	63 Reduced 0.08%	78,091 Ordinary Shares
Feb 06 2021	SELL Payment of exercise price or tax liability	$3,202 $2.9 p/Share	1,104 Reduced 1.41%	76,924 Ordinary Shares

SPG

Steven P. Gelone

Director

Fort Washington, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Value

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nabriva Therapeutics plc

Track Activities on NBRV

Account